Full Press Release Details
SAN DIEGO, March 18, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, today announced that Erik Holmlin, Ph.D., President and Chief Executive Officer, will present on March 19th at the 31st Annual ROTH Conference to be held at The Ritz-Carlton in Orange County, California. The presentation details are as follows:
| Bionano Presentation Details | |
| Date: | Tuesday, March 19 th |
| Time: | 11:30 a.m. Pacific Time |
| Location: | The Ritz-Carlton in Orange County, California |
About Bionano Genomics
Bionano is a life sciences instrumentation company in the genome analysis space. Bionano develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to drive the adoption of digital cytogenetics, a more systematic, streamlined and industrialized form of traditional cytogenetics. The Saphyr system comprises an instrument, chip consumables, reagents and a suite of data analysis tools.
Bionano Genomics, Inc.
Bionano Investor Relations Contact:
LifeSci Advisors, LLC
Bionano Media Contact: